Tumor-Specific Fluorescence-Guided Surgery for Pancreatic Cancer Using Panitumumab-IRDye800CW: A Phase I Dose-Escalation study
暂无分享,去创建一个
B. Martin | E. Rosenthal | G. Lu | G. Poultsides | G. Fisher | N. Nishio | Quan Zhou | Shayan Fakurnejad | Stan van Keulen | G. Yi | R. Raymundo | Stefania U. Chirita | Z. Hart | N. S. Berg
[1] N. S. van den Berg,et al. Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer , 2019, Molecular Imaging and Biology.
[2] N. S. van den Berg,et al. Predicting Therapeutic Antibody Delivery into Human Head and Neck Cancers , 2020, Clinical Cancer Research.
[3] N. S. van den Berg,et al. Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer , 2019, Nature Communications.
[4] Andrew D. Newton,et al. Intraoperative Near-infrared Imaging Can Identify Neoplasms and Aid in Real-time Margin Assessment During Pancreatic Resection. , 2019, Annals of surgery.
[5] B. Martin,et al. The Sentinel Margin: Intraoperative Ex Vivo Specimen Mapping Using Relative Fluorescence Intensity , 2019, Clinical Cancer Research.
[6] B. G. Sibinga Mulder,et al. Impact of resection margin status on recurrence and survival in pancreatic cancer surgery , 2019, The British journal of surgery.
[7] N. S. van den Berg,et al. Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinoma. , 2019, Oral oncology.
[8] N. S. van den Berg,et al. Detection of visually occult metastatic lymph nodes using molecularly targeted fluorescent imaging during surgical resection of pancreatic cancer. , 2018, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[9] Alexander L. Vahrmeijer,et al. Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent , 2018, Annals of Surgical Oncology.
[10] Guolan Lu,et al. Determination of Tumor Margins with Surgical Specimen Mapping Using Near-Infrared Fluorescence. , 2018, Cancer research.
[11] Thinzar M. Lwin,et al. The development of fluorescence guided surgery for pancreatic cancer: from bench to clinic , 2018, Expert review of anticancer therapy.
[12] Eben L. Rosenthal,et al. Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging , 2018, Annals of Surgical Oncology.
[13] Soyeon Ahn,et al. Management of recurrent pancreatic cancer after surgical resection: a protocol for systematic review, evidence mapping and meta-analysis , 2018, BMJ Open.
[14] N. S. van den Berg,et al. Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers , 2018, Theranostics.
[15] J. Kleeff,et al. The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma , 2017, Annals of surgery.
[16] P. Kuppen,et al. Selection of optimal molecular targets for tumor-specific imaging in pancreatic ductal adenocarcinoma , 2017, Oncotarget.
[17] E. Rosenthal,et al. Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer , 2017, Clinical Cancer Research.
[18] Vasilis Ntziachristos,et al. Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study , 2016, Clinical Cancer Research.
[19] Alexander L. Vahrmeijer,et al. Selecting Tumor-Specific Molecular Targets in Pancreatic Adenocarcinoma: Paving the Way for Image-Guided Pancreatic Surgery , 2016, Molecular Imaging and Biology.
[20] Dong Shik Lee,et al. EGFR expression in pancreatic intraepithelial neoplasia and ductal adenocarcinoma. , 2015, International journal of clinical and experimental pathology.
[21] Joshua S Richman,et al. Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer , 2015, Clinical Cancer Research.
[22] Benjamin D. Smith,et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. , 2014, Cancer research.
[23] Cornelis J H van de Velde,et al. Near‐infrared fluorescence‐guided resection of colorectal liver metastases , 2013, Cancer.
[24] Johannes E. Schindelin,et al. Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.
[25] M. Büchler,et al. Pancreatic Cancer Surgery in the New Millennium: Better Prediction of Outcome , 2011, Annals of surgery.
[26] N. Dreyer,et al. Registries for Evaluating Patient Outcomes: A User’s Guide , 2010 .
[27] M. Gagner,et al. Laparoscopic Whipple procedure: review of the literature. , 2009, Journal of hepato-biliary-pancreatic surgery.
[28] Takeaki Ishizawa,et al. Real‐time identification of liver cancers by using indocyanine green fluorescent imaging , 2009, Cancer.
[29] M. Gönen,et al. Preoperative CA 19-9 and the Yield of Staging Laparoscopy in Patients with Radiographically Resectable Pancreatic Adenocarcinoma , 2008, Annals of Surgical Oncology.
[30] J. Donohue,et al. Long-Term Survival After Pancreatoduodenectomy for Pancreatic Adenocarcinoma: Is Cure Possible? , 2008, Annals of surgery.
[31] A. Bhardwaj,et al. Epidermal Growth Factor Receptor Expression in Pancreatic Carcinoma Using Tissue Microarray Technique , 2006, Digestive Surgery.
[32] Y. Ogata,et al. Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings , 2006, Journal of Gastrointestinal Surgery.
[33] R. Wolff,et al. Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] I. Cameron,et al. Indications for staging laparoscopy in pancreatic cancer. , 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[35] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.